Literature DB >> 28138019

Involvement of Host Defense Mechanisms against Toxoplasma gondii Infection in Anhedonic and Despair-Like Behaviors in Mice.

Motamed Elsayed Mahmoud1,2, Ragab Fereig1, Yoshifumi Nishikawa3.   

Abstract

Toxoplasma gondii is a pathogen relevant to psychiatric disorders. We recently showed that reactivation of chronic T. gondii infection induced depression-like behaviors in mice. Furthermore, it has been hypothesized that depression-like behaviors are mediated via a host defense mechanism against invading pathogens; proximate mechanisms of this behavioral hypothesis remain unclear. In the present study, we investigate the contribution of indoleamine 2,3-dioxygenase (IDO), inflammation, and interferon gamma (IFN-γ) to anhedonic and despair-related behaviors in T. gondii-infected mice by using sucrose preference and forced-swim tests, respectively. First, we confirmed that BALB/c mice exhibited both sickness and depression-like behaviors during acute infection. Treatment of infected wild-type mice with minocycline (anti-inflammatory drug) abated sickness and anhedonic and despair-like behaviors, whereas in T. gondii-infected mice, treatment normalized kynurenine/tryptophan (Kyn/Trp) ratios in both plasma and brain tissue. Additionally, T. gondii infection failed to induce anhedonic and despair-like behaviors or increase the Kyn/Trp ratio in immunocompromised (IFN-γ-/-) mice, whereas sickness behavior was observed in both immunocompetent and IFN-γ-/- mice following infection. Furthermore, treatment with 1-methyl tryptophan (an IDO inhibitor) did not affect locomotor activity, attenuated clinical scores and anhedonic and despair-like behaviors, and resulted in normal Kyn/Trp ratios in T. gondii-infected wild-type mice. Although low levels of serotonin and dopamine were observed in the brain during acute and chronic infections, anhedonic and despair-like behaviors were not detected in the chronic stage of infection. Collectively, our results demonstrated that immune enhancement in response to infection with T. gondii resulted in IFN-γ production, IDO activation, and inflammation associated with anhedonic and despair-like behaviors.
Copyright © 2017 American Society for Microbiology.

Entities:  

Keywords:  1-methyl tryptophan; Toxoplasma gondii; anhedonic behavior; despair-like behavior; interferon gamma; minocycline; sickness behavior

Mesh:

Substances:

Year:  2017        PMID: 28138019      PMCID: PMC5364308          DOI: 10.1128/IAI.00007-17

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  72 in total

1.  Minocycline inhibits cytochrome c release and delays progression of amyotrophic lateral sclerosis in mice.

Authors:  Shan Zhu; Irina G Stavrovskaya; Martin Drozda; Betty Y S Kim; Victor Ona; Mingwei Li; Satinder Sarang; Allen S Liu; Dean M Hartley; Du Chu Wu; Steven Gullans; Robert J Ferrante; Serge Przedborski; Bruce S Kristal; Robert M Friedlander
Journal:  Nature       Date:  2002-05-02       Impact factor: 49.962

2.  Inhibitory effects of U73122 and U73343 on Ca2+ influx and pore formation induced by the activation of P2X7 nucleotide receptors in mouse microglial cell line.

Authors:  Takato Takenouchi; Kazumasa Ogihara; Mitsuru Sato; Hiroshi Kitani
Journal:  Biochim Biophys Acta       Date:  2005-08-15

3.  Potential regulatory function of human dendritic cells expressing indoleamine 2,3-dioxygenase.

Authors:  David H Munn; Madhav D Sharma; Jeffrey R Lee; Kanchan G Jhaver; Theodore S Johnson; Derin B Keskin; Brendan Marshall; Phillip Chandler; Scott J Antonia; Russell Burgess; Craig L Slingluff; Andrew L Mellor
Journal:  Science       Date:  2002-09-13       Impact factor: 47.728

4.  A gene(s) within the H-2D region determines the development of toxoplasmic encephalitis in mice.

Authors:  Y Suzuki; K Joh; M A Orellana; F K Conley; J S Remington
Journal:  Immunology       Date:  1991-12       Impact factor: 7.397

5.  Evidence for a tumoral immune resistance mechanism based on tryptophan degradation by indoleamine 2,3-dioxygenase.

Authors:  Catherine Uyttenhove; Luc Pilotte; Ivan Théate; Vincent Stroobant; Didier Colau; Nicolas Parmentier; Thierry Boon; Benoît J Van den Eynde
Journal:  Nat Med       Date:  2003-09-21       Impact factor: 53.440

6.  Stress-induced anhedonia in mice is associated with deficits in forced swimming and exploration.

Authors:  Tatyana Strekalova; Rainer Spanagel; Dusan Bartsch; Fritz A Henn; Peter Gass
Journal:  Neuropsychopharmacology       Date:  2004-11       Impact factor: 7.853

7.  The clinical response to minocycline in multiple sclerosis is accompanied by beneficial immune changes: a pilot study.

Authors:  R K Zabad; L M Metz; T R Todoruk; Y Zhang; J R Mitchell; M Yeung; D G Patry; R B Bell; V W Yong
Journal:  Mult Scler       Date:  2007-02-09       Impact factor: 6.312

8.  A prospective study of the incidence and open-label treatment of interferon-induced major depressive disorder in patients with hepatitis C.

Authors:  P Hauser; J Khosla; H Aurora; J Laurin; M A Kling; J Hill; M Gulati; A J Thornton; R L Schultz; A D Valentine; C A Meyers; C D Howell
Journal:  Mol Psychiatry       Date:  2002       Impact factor: 15.992

9.  Interleukin-12 enhances murine survival against acute toxoplasmosis.

Authors:  I A Khan; T Matsuura; L H Kasper
Journal:  Infect Immun       Date:  1994-05       Impact factor: 3.441

10.  Toll-like receptor-2 deficiency induces schizophrenia-like behaviors in mice.

Authors:  Se Jin Park; Jee Youn Lee; Sang Jeong Kim; Se-Young Choi; Tae Young Yune; Jong Hoon Ryu
Journal:  Sci Rep       Date:  2015-02-17       Impact factor: 4.379

View more
  11 in total

1.  CCR5 Is Involved in Interruption of Pregnancy in Mice Infected with Toxoplasma gondii during Early Pregnancy.

Authors:  Maki Nishimura; Kousuke Umeda; Masayuki Suwa; Hidefumi Furuoka; Yoshifumi Nishikawa
Journal:  Infect Immun       Date:  2017-08-18       Impact factor: 3.441

Review 2.  Impact of Plant-Based Foods and Nutraceuticals on Toxoplasma gondii Cysts: Nutritional Therapy as a Viable Approach for Managing Chronic Brain Toxoplasmosis.

Authors:  Sijie Tan; Wen Han Tong; Ajai Vyas
Journal:  Front Nutr       Date:  2022-02-25

Review 3.  Meat Intake and the Dose of Vitamin B3 - Nicotinamide: Cause of the Causes of Disease Transitions, Health Divides, and Health Futures?

Authors:  Lisa J Hill; Adrian C Williams
Journal:  Int J Tryptophan Res       Date:  2017-05-03

Review 4.  Catastrophic consequences: can the feline parasite Toxoplasma gondii prompt the purrfect neuroinflammatory storm following traumatic brain injury?

Authors:  Tamara L Baker; Mujun Sun; Bridgette D Semple; Shiraz Tyebji; Christopher J Tonkin; Richelle Mychasiuk; Sandy R Shultz
Journal:  J Neuroinflammation       Date:  2020-07-25       Impact factor: 8.322

5.  The antidepressant impact of minocycline in rodents: A systematic review and meta-analysis.

Authors:  Daniel J Reis; Emily J Casteen; Stephen S Ilardi
Journal:  Sci Rep       Date:  2019-01-22       Impact factor: 4.379

Review 6.  Behavioral biology of Toxoplasma gondii infection.

Authors:  Wen Han Tong; Chris Pavey; Ryan O'Handley; Ajai Vyas
Journal:  Parasit Vectors       Date:  2021-01-25       Impact factor: 3.876

7.  Ginsenoside Rh2 reduces depression in offspring of mice with maternal toxoplasma infection during pregnancy by inhibiting microglial activation via the HMGB1/TLR4/NF-κB signaling pathway.

Authors:  Xiang Xu; Yu-Nan Lu; Jia-Hui Cheng; Hui-Wen Lan; Jing-Mei Lu; Guang-Nan Jin; Guang-Hua Xu; Cheng-Hua Jin; Juan Ma; Hu-Nan Piao; Xuejun Jin; Lian-Xun Piao
Journal:  J Ginseng Res       Date:  2021-04-28       Impact factor: 6.060

8.  Are Toxoplasma-infected subjects more attractive, symmetrical, or healthier than non-infected ones? Evidence from subjective and objective measurements.

Authors:  Javier I Borráz-León; Markus J Rantala; Indrikis A Krams; Ana Lilia Cerda-Molina; Jorge Contreras-Garduño
Journal:  PeerJ       Date:  2022-03-25       Impact factor: 2.984

Review 9.  Neurophysiological Changes Induced by Chronic Toxoplasma gondii Infection.

Authors:  Ellen Tedford; Glenn McConkey
Journal:  Pathogens       Date:  2017-05-17

10.  Toxoplasma gondii α-amylase deletion mutant is a promising vaccine against acute and chronic toxoplasmosis.

Authors:  Jing Yang; Chenghang Yang; Jiahui Qian; Facai Li; Junlong Zhao; Rui Fang
Journal:  Microb Biotechnol       Date:  2020-09-22       Impact factor: 5.813

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.